BOSTON — Researchers from Boston University and Banner Health say they have identified a blood-based method that may help detect chronic traumatic encephalopathy, or CTE, during a person’s lifetime. The study, published in JAMA on November 19, examined blood samples from 21 former American football players who later donated their brains for research. Banner Health’s research announcement described the findings.

CTE is a neurodegenerative disease associated with repeated head impacts. It has been identified in athletes and others exposed to repetitive brain trauma, but definitive diagnosis has traditionally required examination of brain tissue after death. A reliable blood test could change research and clinical practice by making it easier to identify people for monitoring and future trials.

The researchers analysed biomarkers in blood samples collected during life and compared them with brain pathology identified after death. The authors reported that the method could detect CTE-related pathology in the study group. The small number of participants means the results need confirmation in larger and more diverse populations.

A blood test would be important for former contact-sport athletes who experience memory, mood, behavioural or cognitive changes. However, those symptoms can have many causes, and the study does not mean a commercial diagnostic test is immediately available or that a positive result can determine an individual’s prognosis.

Further studies must establish how well the test performs in living patients, how it distinguishes CTE from other neurological conditions and whether early detection can guide effective treatment. More health research news.